case_images: PMC9478730_01
case_images: The preoperative CT images of the liver.
case_images: fonc-12-951303-g001.jpg
case_images: PMC9478730_01_fonc-12-951303-g001.jpg
case_images: f1
case_images: Upper abdominal enhanced Computed Tomography (CT) showed HCC (number of lesions > 10), liver cirrhosis, and portal hypertension ( Figure 1 ).
case_images: The trend chart of AFP and AFP-L3 after operation.
case_images: fonc-12-951303-g002.jpg
case_images: PMC9478730_01_fonc-12-951303-g002.jpg
case_images: f2
case_images: After 2 weeks of lenvatinib, AFP level increased to 1038 ng/ml, AFP-L3 level increased to 260.7 ng/ml, and PIVKA-II level increased slightly ( Figure 2 ). AFP and AFP-L3 continued to decrease and no rejection ( Figure 2 ). At present, two years after liver transplantation, the levels of AFP and AFP-L3 have decreased to normal level.
case_images: Treatment flow chart.
case_images: fonc-12-951303-g003.jpg
case_images: PMC9478730_01_fonc-12-951303-g003.jpg
case_images: f3
case_images: The treatment flow chart is shown in  Figure 3 .